Beatrice Langton-Webster Selected Research

Prostatectomy (Retropubic Prostatectomy)

1/2019

Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Beatrice Langton-Webster Research Topics

Disease

3	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2017
2	Neoplasms (Cancer) 01/2020 - 01/2017
1	Cystic Fibrosis (Mucoviscidosis) 01/2010

Drug/Important Bio-Agent (IBA)

3	AntigensIBA 01/2020 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	phosphoramidic acidIBA 01/2019 - 01/2017
1	RadiopharmaceuticalsIBA 01/2019
1	AlbuminsIBA 01/2017
1	INO-4995IBA 01/2010

Therapy/Procedure

1	Injections 01/2020
1	Castration 01/2019
1	Prostatectomy (Retropubic Prostatectomy) 01/2019